REFERENCES

 

Altman RD  Dean DD  Muniz OE  Howell DS  (1989)

Prophylactic treatment of canine osteoarthritis with glycosaminoglycan polysulfuric acid ester

Arthritis Rheum  32  759-766

 

Andermann G and Dietz M  (1982)

The influence of the route of administration on the bioavailability of an endogenous macromolecule:  chondroitin sulphate (CSA)

Eur J Drug Metab Pharmacol  7 (1)  11-16

 

Anderson CC  Cook JL Kreeger JM  Tomlinson JL and Wagner-Mann CC  (1999)

In vitro effects of glucosamine and acetylsalicylate on canine chondrocytes in three-dimensional culture

Am J Vet Res  60  1546-1551

 

Avouac B  (1993)

Slow Acting Drugs in Osteoarthritis:  a step towards disease modification

Rev Esp Reumatol  20 (Suppl 1)  221-222

 

Baici A  Horler D  Moser B et al  (1992)

Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulphate

Rheumatol Int  12  81-88

 

Bassleer C  Henrotin Y and Franchiment P  (1992)

In vitro evaluation of drugs proposed as chondroprotective agents

Int J Tissue React  14  231-241

 

Bassleer C  Reginster JY and Franchiment P  (1993)

Effects of glucosamine on differentiated human chondrocytes cultivated in clusters

Rev Esp Reumatol  20 (Suppl 1)  96

 

Bennet D  (1980)

The naturally occurring inflammatory arthropathies of the dog

PhD thesis, University of Glasgow

 

Bennet D  May C  (1995)

Joint diseases of dogs and cats

In  Textbook of veterinary internal medicine 4th ed

Eds:  Ettinger SJ  Feldman EC

Vol II  2032-2077

 

Booth DM  (1995)

The analgesic-antipyretic-anti-inflammatory drugs

In Veterinary pharmacology and therapeutics 7th ed

Ed:  Adams HR

Iowa State University Press/Ames  pp 432-449

 

Bourgeois P  Charles G  Dehais J  Delcambue B  Kuntz J-L and Rozenberg S  (1998)

Efficacy and tolerability of chondroitin sulfate 1200mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo

Osteoarthritis and Cartilage  6  25-30

 

Brandt KD  (1987)

Nonsteroidal anti-inflammatory drugs and articular cartilage

J Rheum  14  132-133

 

Brandt KD  and Slowman-Kovacs SD  (1986)

Nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis

Clin Orthop  213  84-91

 

Bucsi L and Poór G  (1998)

Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis

Osteoarthritis and Cartilage  6  31-36

 

Burkhardt D and Ghosh P  (1987)

Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents

Sem Arth Rheum  17  (2)  Suppl 1  3-34

 

Canapp SO  McLaughlin RM  Huskinson JJ  Roush JK  and Butrie MD  (1999)

Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulfate

Am J Vet Res  60 (12)  1552-1557

 

Carreno MR  Muniz OE  Howell DS  (1986)

The effect of glycosaminoglycan polysulfuric acid ester on articular cartilage in experimental osteoarthritis:  effects of morphological parameters of disease severity

J Rheumatol  13  490-497

 

Clark CC  Richards CF and Iozzo RV  (1991)

Post-translational alternations in newly synthesised cartilage proteoglycans induced by the glutamine analogue 6-diazo-5-oxo-L-norleucine

Biochem J  273  283-288

 

Clark DM  (1991)

The biochemistry of degenerative joint disease and its treatment

Comp Cont Ed Pract Vet  13  275-284

 

Conte A  De Bernardi M  Palmieri L et al  (1991)

Metabolic fate of exogenous chondroitin sulphate in man

Arneimittelforsch/Drug Res  41  768-772

 

Conte A  Volpi N  Palmieri L  Bahous I and Ronca G  (1995)

Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulphate

Drug Res  45  918-925

 

Coughlan AR  (1998)

Osteoarthritis

In  Canine medicine and therapeutics 4th ed

Ed:  Gorman NT

Blackwell Science Ltd  London  770-780

 

Crolle G and D’Est E  (1980)

Glucosamine sulphate for the management of arthrosis:  a controlled clinical investigation

Curr Res Med opinion  7 (2)  114-119

 

D’Ambrosio E  Casa B  Bompani R  Scali G and Scali M  (1981)

Glucosamine sulphate:  a controlled clinical investigation in arthrosis

Pharmatherapeutica  2 (8)  504-508

 

de Haan JJ  Goring RL  Beale BS  (1994a)

Evaluation of polysulfated glycosaminoglycan for the treatment of hip dysplasia in dogs

Dept of Small Animal Clinical Sciences  23  177-181

 

de Haan JJ  Beale BS  Clemmons RM  et al  (1994b)

The effects of polysulfated glycosaminoglycan (Adequan) on activated partial thromboplastin time, prothrombin time, complete blood count, biochemical profile and urinalysis in cats.

Vet Comp Orthop Trauma  7  77-81

 

Dohlman  CH  (1956)

The fate of the sulfate group of chondroitin sulfate after administration to rats

Acta Physiol Scand  37  220-234

 

Drovanti A  Bignamini AA and Rovati AL  (1980)

Therapeutic activity of oral glucosamine sulphate in osteoarthritis:  a placebo-controlled double-blind investigation

Clin Ther 3 (4)  260-272

 

Eichler J and Nöh E  (1970)

Therapy of deforming arthrosis through the action upon the cartilagenous metabolism

Orthop Prax  9  225-229

 

Fenton  JI et al  (1999a)

Glucosamine inhibits cartilage degradation in equine articular cartilage explants

J Eq Vet Sci  19  (7)  454

 

Fenton JI  Chelebek-Brown KA  Peters TL and Canon JP  (1999b)

Glucosamine inhibits interleukin -1b and lipopolysaccharide-induced cartilage degradation in vitro

Vet Surg  28  388

 

Ghosh P  (1990)

Chondroprotective drugs and osteoarthritis

Ann Rheum Dis  49  338-339

 

Ghosh P  Smith M  Wells C  (1991)

Second line agents in osteoarthritis

In  Second line agents in the treatment of rheumatic diseases

Eds:  Dixon JS  Furst DE

Marcel Dekker Inc  363-427

 

Ghosh P  Wells C  Smith M and Hutadilok N  (1990)

Chondroprotection, myth or reality:  an experimental approach

Sem Arthritis Rheum  19  3-9

 

Giocovelli G and Rovati LC  (1993)

Clinical efficacy of glucosamine sulfate in osteoarthritis of the spine

Rev Esp Reumatol  20 (Suppl 1)  96

 

Hannan N  Gosh P  Bellenger C  Taylor T  (1987)

Systemic administration of glycosaminoglycan polysulfate (Arteparon) provides partial protection of articular cartilage from damage produced by meniscectomy in the canine

J Orthrop Res  5  47-59

 

Herman J  Apel A  Khosha R and Hess EV  (1986)

The in vitro effect of select classes of non-steroidal anti-inflammatory drugs on normal cartilage metabolism

J Rheumatol  13  1014-1018

 

Hulse D  (1998)

Treatment methods for pain in the osteoarthritic patient

Vet Clin North Am Small Anim Pract  28  361-374

 

Humphrey D  (1999)

Personal communication

 

Johnston SA  (1997)

Osteoarthritis:  joint anatomy, physiology and pathobiology

Vet Clin North Am Small Anim Pract  27  699-723

 

Jones RD  Baynes RE  Nimitz CT  (1992)

Nonsteroidal anti-inflammatory drug toxicosis in dogs and cats:  240 cases  (1989-1990)

J Am Vet Med Assoc  201  475-477

 

Karzel K and Domenjoz R  (1971)

Effects of hexosamine derivatives and uronic acid derivatives on glycosaminoglycan metabolism of fibroblast cultures

Pharmacology  5  337-345

 

Kim JA and Conrad HE  (1974)

Effect of D-glucosamine concentration on the kinetics of mucopolysaccharide biosynethesis in cultured chick embryo vertebral cartilage

J Biol Chem  249  3091-3097

 

Konador A and Kawiak J  (1977)

Changes in chondroitin sulfate concentration in rabbit blood plasma depending on the method of its administration

Arch Immunol Ther Exp (Warsz)  25  895-903

 

L’Hirondel JL  (1992)

Klinische Doppelblind-Studie mit oral verabreichtem Chondroitinsulfat gegen Placebo bei der tibiofemoralen Gonarthrose (125 Patienten)

In  Orales Chondroitinsulfat bei Arthrose

Eds:  Lequesne M  Lualdi P  Numo R

Eular Verlag Basel  77-84

 

Latino D  (1999)

Personal communication

 

Lequesne M  (1993)

Guidelines for testing slow acting drugs in osteoarthritis (SADOAs)

Rev Esp Rheumatol  20 (Suppl 1) 220-221

 

Lequesne M  Brandt K  Bellamy N  Moskowitz R  Menkes CJ  Pelletier JP  Altman R (1994)

Guidelines for testing Slow Acting Drugs in Osteoarthritis

J Rheumatol  20 (Suppl) 65-73

 

Lipowitz AJ  (1993)

Degenerative joint disease

In  Textbook of small animal surgery 2nd ed

Ed:  Slatter D

W B Saunders Co  pp 1921-1927

 

Lualdi P  (1993)

Bioavailability of oral chondroitin sulfate

Rheumatol Int  13  39-40

 


 

Lust G  Williams AJ  Burton-Wurster N  Beck KA  Rubin G  (1992)

Effects on intramuscular administration of glycosaminoglycan polysulfates on signs of incipient hip dysplasia in growing pups

Am J Vet Res  53  1836-1843

 

McDonald RK and Lanston VS  (1995)

Use of corticosteroids and nonsteroidal anti-inflammatory agents

In  Textbook of veterinary internal medicine

Ed:  Ettinger SJ

W B Saunders Co  Philadelphia  pp  284-293

 

McKenzie LS  Horsburgh BA  Ghosh P  and Taylor TKF  (1976)

Osteoarthrosis:  uncertain rationale for anti-inflammatory drug therapy

Lancet  1  908

 

McNamara PS  Barr SC  Erb HN  (1996)

Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days

AJVR 57  1390-1394

 

Moore MG  (1996)

Promising responses to a new oral treatment for degenerative joint disorders

Canine practice  21  7-11

 

Morveale P  Manopulo R  Galati M  Boccarera L  Saponati G and Bocchi L  (1996)

Comparison of the anti-inflammatory efficacy of chondroitin sulphate and diclofenac sodium in patients with knee osteoarthritis

J Rheumatol  23  1385-1391

 

Moskowitz RW  Davis W  Sammarco J  Mast W  and Chase SW  (1970)

Experimentally induced corticosteroid arthropathy

Arthritis Rheum  13  236-243

 

Müller-Fassbender H  Bach GL  Haase W  Rovati LC and Setnikar I  (1994)

Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee

Osteoarthritis and Cartilage  2  61-69

 

Mund-Hoyn W-D  (1980)

Medical treatment of spinal arthrosis with glucosamine or phenylbutazone.  A controlled study.

Therapiewoche  30  5922-5928

 

Murnane TW and Belt WD  (1972)

Uptake of tritiated glucosamine by femur and mandible of 7-day old and adult mice

J Dent Res  51  652-656

 


 

Nelson RW  Couto CG  (1998)

Noninflammatory joint disease

In  Small Animal Internal Medicin 2nd ed

Mosby Inc St Louis  1076-1078

 

Németh-Csóka M  Kajtár M and Kajtár J  (1977)

The role of sulphation of glycosaminoglycans in their structural and functional characteristics

Connect Tissue Res  5  1-6

 

Noack W  Fischer M  Förster KK  Rovati LC and Setnikar I  (1994)

Glucosamine sulfate in osteoarthritis of the knee

Osteoarthritis Cart  2  51-59

 

Palmieri L  Conte A  Giovannini L  Lualdi P and Ronca G  (1990)

Metabolic fate of exogenous chondroitin sulfate in the experimental animal

Arzeim Forsch/Drug Res  40  319-323

 

Palmoski MJ  Brandt KD  (1979)

Effect of salicylate on proteoglycan metabolism in normal canine articular cartilage in vitro

Arthritis Rheum  22  746-754

 

Palmoski MJ  Brandt KD  (1980)

Effects of some nonsteroidal anti-inflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage

Arthritis Rheum  23  1010-1019

 

Palmoski MJ  Brandt KD  (1983)

Relationship between matrix proteoglycan content and the effects of salicylate and indomethacin on articular cartilage

Arthritis Rheum  26  528-531

 

Paroli E  Antonilli L and Biffoni M  (1991)

A pharmacological approach to glycosaminoglycans

Drugs Exp Clin Res 17  9-19

 

Pettipher ER  Henderson B  Edwards JCW  and Higgs GA  (1986)

Indomethacin enhances proteoglycan loss from articular cartilage in antigen-induced arthritis

Br J Pharmacol  94  342

 

Plumb DC  (1995)

Nonsteroidal anti-inflammatory agents

In Veterinary drug handbook

Ed:  Plumb DC

Pharma Vet Publishing  Minn  pp  34-36

 


 

Pujalte JM  Llavore EP and Ylescupidez FR  (1980)

Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthritis

Curr Res Med Opinion  7 (2)  110-114

 

Raiss R  (1985)

Influence of glucosamine sulfate on experimentally impaired articular cartilage:  test of ultrastructural changes in chondrocytes using morphometry

Fortschr Med  103  658-662

 

Rashad S  Revell P  Hemingway A  Low F  Rainsford K  and Walker F  (1989)

Effect of nonsteroidal anti-inflammatory drugs on the course of osteoarthritis

Lancet  2  519-522

 

Reichelt A  Fuorster KK  Fischer M  Rovati LC and Setnikar I  (1994)

Efficacy and safety of intramuscular glucosamine sulphate in osteoarthritis of the knee

Arneim-Forsch/Drug Research  44  74-80

 

Rejholec V  (1987)

Long-term studies of antiosteoarthritic drugs:  an assessment

Semin Arthritis Rheum  17  35-53

 

Rodén L  (1956)

Effect of hexosamines on the synthesis of chondroitin sulphuric acid in vitro

Arkh Kemi  10  345-352

 

Ronca F  Palmieri L  Panicucci P and Ronca G  (1998)

Anti-inflammatory activity of chondroitin sulphate

Osteoarthritis and Cartilage  6 (Suppl A)  14-21

 

Ronca G and Conte A  (1993)

Metabolic fate of partially depolymerised shark chondroitin sulfate in man

Int J Clin Pharm Res  13  27-34

 

Rovati LC  Setnikar I  Förster KK  REichlert A and Noack W  (1993)

Glucosamine sulfate in gonarthrosis:  efficacy in placebo controlled studies

Rev Esp Reumatol  20 (Suppl 1)  72

 

Salyers AA (1979)

Energy sources of major intestinal fermentative anaerobes

Am J Clin Nutr  32  158-163

 

Salyers AA and O’Brien M  (1980)

Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thelaiotaomicron

J Bacteriol  143  772-780

 


 

Schiavinato A  Lini E  Guidolin D  et al  (1989)

Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs  II Morphological findings

Clin Orthop  241  286-299

 

Serni V  (1993)

Profile of glucosamine sulfate as an example of Slow Acting Drug in Osteoarthritis

Rev Esp Reumatol  20 (Suppl 1)  222

 

Setnikar I  Cereda R  Pacini MA and Revel L  (1991a)

Antireactive properties of glucosamine sulphate

Arzneim-Forsch/Drug Res  41  157-161

 

Setnikar I  Giachetti C and Zanolo G  (1984)

Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat

Pharmacotherapeutica  3  538-550

 

Setnikar I  Giachetti C and Zanolo G  (1986)

Pharmacokinetics of glucosamine in the dog and man

Arzneim Forsch/Drug Res  36 729-735

 

Setnikar I  Pacini MA and Revel L  (1991b)

Antiarthritic effects of glucosamine sulphate studies on animal models

Arzneim-Forsch/Drug Res  542-545

 

Setnikar I  Palumbo R  Canali S and Zonolo G  (1993)

Pharmacokinetics of glucosamine in man

Arzneim Forsch/Drug Res  43  1109-1113

 

Slowman-Kovacs SD  Albrecht ME and Brandt KD  (1989)

Effects of salicylates on chondrocytes from osteoarthritic and contralateral knees of dogs with unilateral anterior cruciate ligament transection

Arthritis Rheum  32  486-490

 

Tapadinhas MJ  Rivera IC and Bignamini AA  (1982)

Oral glucosamine sulphate in the management of arthrosis:  report on a multicentre open investigation in Portugal

Pharmatherapeutica  3 (3)  157-168

 

Tesoriere G  Dores F  Magistro D et al  (1972)

Intestinal absorption of glucosamine and N-acetylglucosamine

Experertia  28  770-771

 

Todhunter RJ  and Lust G  (1994)

Polysulfated glycosaminoglycan in the treatment of osteoarthritis

J Am Vet Med Assoc  204  1245-1251

 

Trotter GW  (1996)

Polysulfated glycosaminoglycan (Adequan)

In Joint Disease in the Horse

Eds:  C Wayne McIlwraith and Gayle W Trotter

WB Saunders Co  Philadelphia  pp 270-280

 

Uebelhart D  Thonar EJ-MA  Delmas PD  Chantraine A and Vignon E  (1998a)

Effects of oral chondroitin sulfate on the progression of knee osteoarthritis:  a pilot study

Osteoarthritis and Cartilage  6 (Suppl A)  39-46

 

Uebelhart D  Thonar EJ-MA  Zhang J and Williams JM  (1998b)

Protective effect of exogenous chondroitin 4, 6-sulfate in the acute degradation of articular cartilage in the rabbit

Osteoarthritis and Cartilage  6 (Suppl A)  6-13

 

Vajardul Y  (1981)

Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis

Clin Ther  3 (5)  336-343

 

Vaz AL  (1982)

Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in outpatients

Curr Med Res Opinion  8 (3)  145-149

 

Vetter von G  (1969)

Lokale therapie der arthrosen mit glukosaminen  (Dona 200)

Munch Med Wochenschr  III  1499-1502

 

Vidal y Plana RR  Bizzarri D and Rovati AL (1978)

Articular cartilage pharmacology.  In vitro studies on glucosamine and nonsteroidal anti-inflammatory drugs

Pharmacol Res Comm  10  557-569

 

Vidal y Plana RR and Karzel K  (1980)

Glucosamine:  its role in the articular cartilage metabolism 2.  Studies on rat and human articular cartilage

Fortschr Med  98  801-806

 

Yamanashi S  Toyoda H  Furuya N  Harada T  Yoshida K  Toida T and Imanari T       

(1991)

Metabolic study on chondroitin sulfate in rabbits

Yakagaku Zasshi  III  73-76